Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 1
2011 4
2012 3
2013 18
2014 37
2015 5
2016 5
2017 14
2018 10
2019 4
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Monitoring strategies for clinical intervention studies.
Klatte K, Pauli-Magnus C, Love SB, Sydes MR, Benkert P, Bruni N, Ewald H, Arnaiz Jimenez P, Bonde MM, Briel M. Klatte K, et al. Cochrane Database Syst Rev. 2021 Dec 8;12(12):MR000051. doi: 10.1002/14651858.MR000051.pub2. Cochrane Database Syst Rev. 2021. PMID: 34878168 Free PMC article. Review.
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Carmona Echeverria LM, Haider A, Freeman A, Stopka-Farooqui U, Rosenfeld A, Simpson BS, Hu Y, Hawkes D, Pye H, Heavey S, Stavrinides V, Norris JM, Bosaily AE, Cardona Barrena C, Bott S, Brown L, Burns-Cox N, Dudderidge T, Henderson A, Hindley R, Kaplan R, Kirkham A, Oldroyd R, Ghei M, Persad R, Punwani S, Rosario D, Shergill I, Winkler M, Ahmed HU, Emberton M, Whitaker HC. Carmona Echeverria LM, et al. Sci Rep. 2020 Oct 14;10(1):17177. doi: 10.1038/s41598-020-73524-z. Sci Rep. 2020. PMID: 33057024 Free PMC article.
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Malla SB, Fisher DJ, Domingo E, Blake A, Hassanieh S, Redmond KL, Richman SD, Youdell M, Walker SM, Logan GE, Chatzipli A, Amirkhah R, Humphries MP, Craig SG, McDermott U, Seymour MT, Morton DG, Quirke P, West NP, Salto-Tellez M, Kennedy RD, Johnston PG, Tomlinson I, Koelzer VH, Campo L, Kaplan RS, Longley DB, Lawler M, Maughan TS, Brown LC, Dunne PD; S:CORT consortium. Malla SB, et al. Clin Cancer Res. 2021 Jan 1;27(1):288-300. doi: 10.1158/1078-0432.CCR-20-3237. Epub 2020 Oct 7. Clin Cancer Res. 2021. PMID: 33028592 Free PMC article.
Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Thomas DS, Gentry-Maharaj A, Ryan A, Fourkala EO, Apostolidou S, Burnell M, Alderton W, Barnes J, Timms JF, Menon U. Thomas DS, et al. Cancer Epidemiol. 2019 Feb;58:167-174. doi: 10.1016/j.canep.2018.11.011. Epub 2019 Jan 4. Cancer Epidemiol. 2019. PMID: 30616086 Free PMC article. Clinical Trial.
96 results